Human Milk Oligosaccharides (HMO) Market to Reach $1.82 Billion by 2034, Growing at a CAGR of 22.6%

The global human milk oligosaccharides (HMO) market is anticipated to grow significantly, according to the newly published research report by Polaris Market Research. The market was valued at USD 255.86 million in 2024 and is projected to grow to USD 1,821.29 million by 2034. This growth signifies a robust compound annual growth rate (CAGR) of 22.60% over the forecast period 2025-2034.

Market Explanation
Human milk oligosaccharides (HMOs) are a diverse group of unconjugated glycans and the third most abundant solid component in human milk. These oligosaccharides are highly variable in structure, with over 200 different types identified to date. HMOs play a vital role in the development of new-borns, particularly in supporting the growth of beneficial gut bacteria, enhancing the immune system, and promoting the physical and cognitive development of infants. They are considered essential for infant nutrition, as they contribute to the colonization of the gastrointestinal tract and influence long-term health outcomes.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/request-for-sample

Key Players
The market has the presence of both established players and new entrants. Some of the major players in the market are:
• Abbott Laboratories
• BASF S.E.
• Biosynth Carbosynth
• Chr. Hansen Holding A/S
• Dextra Laboratories Ltd.
• Dupont Nutrition & Biosciences
• Elicityl S.A.
• Glycosyn
• Inbiose NV
• Medolac Laboratories
• Neolacta Lifesciences Pvt. Ltd.
• Nestle Health Science
• Royal DSM
• Royal FrieslandCampina N.V.
• ZuChem

Human Milk Oligosaccharides Market Report Highlights
• Based on type, the 2'FL segment led the HMO market share in 2024, representing 54.16% of revenue. Its high demand is attributed to its significant health benefits, particularly in infant nutrition.

• The human milk oligosaccharides market, by distribution channel, is segmented into hypermarkets & supermarkets, drug store or pharmacy, online sales channel, and others. The hypermarkets & supermarkets play a crucial role in the distribution of human milk oligosaccharides (HMO)-enriched products due to their widespread presence, high foot traffic, and ability to offer a diverse range of products.

• In 2024, Asia Pacific dominated the human milk oligosaccharides market revenue share, primarily fueled by the region's expanding population and rising birth rates, especially in countries such as China and India.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/request-for-discount-pricing

Market Drivers
Growing Demand for Infant Nutrition
As consumers growingly look for options for breastfeeding, there is an escalating demand for infant formulas that mirror the advantages of natural breast milk. HMO support immune operation, gut health, and cognitive advancement, which are important for infant development. Their involvement in infant formula assists in confronting the nutritional fissures for infants that cannot be breastfed, making them an important constituent of contemporary infant nutrition. This, in turn, fuels the human milk oligosaccharides market growth.

Rising Focus on Gut Health
The growing concentration on gut health, dispensation, and holistic wellness is driving the demand for prebiotics and probiotics, with human milk oligosaccharides being an indispensable part of both classifications. Human milk oligosaccharides are acknowledged to behave as prebiotics, encouraging the growth of favorable gut bacteria and furthering a stabilized microbiome.

Segment Wise Insights
The human milk oligosaccharides (HMO) market is segmented based on type, application, distribution channel, and region.
Based on type, the 2'FL segment dominated the market in 2024 owing to the extensive usage of 2'FL in infant nutrition, where it mimics the advantages of natural breast milk.
Based on distribution channel, the hypermarkets & supermarkets segment is expected to register a robust CAGR due to growing consumer inclination for agreeable in-store shopping experiences.

By Type Outlook (Revenue - USD Million, 2020-2034)
 2'FL
 3'FL
 3'SL
 6'SL

By Application Outlook (Revenue - USD Million, 2020-2034)
 Infant Formula
 Functional Food & Beverage
 Food Supplements

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)
 Hypermarkets & Supermarkets
 Drug Store or Pharmacy
 Online Sales Channel
 Others

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market

Regional Outlook
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

More Trending Latest Reports by Polaris Market Research:
Tuna Fish Market
https://www.polarismarketresearch.com/industry-analysis/tuna-fish-market

Human Milk Oligosaccharides (HMO) Market
https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market

Vanillin Market
https://www.polarismarketresearch.com/industry-analysis/vanillin-market

Protein Crisps Market
https://www.polarismarketresearch.com/industry-analysis/protein-crisps-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.